Immunoreactivity of monoclonal anti-melanoma antibodies in relation to the amount of radioactive iodine substituted to the antibody molecule
- PMID: 4076233
- DOI: 10.1007/BF00279081
Immunoreactivity of monoclonal anti-melanoma antibodies in relation to the amount of radioactive iodine substituted to the antibody molecule
Abstract
The damage to monoclonal anti-melanoma antibodies caused by iodination was investigated by comparing the results obtained using the chloramine-T method and the 1,3,4,6-tetrachloro-3 alpha, 6 alpha-diphenyl-glycoluril (IODOGEN) method at different levels of iodine substitution to the molecule. The level of substitution at which losses in immunoreactivity occurred was evaluated in each monoclonal antibody (MAb) studied. This phenomenon was not dependent on the method of substitution, provided that mild conditions of reaction were used. Lineweaver-Burk plots and--in cases of alterations in binding affinity--Scatchard plots were found to provide an adequate description of the binding behaviour of individual MAbs after labelling. Immunoreactivity was shown to be determined not only by the proportion of bona fide reactive MAb molecules, but also by a substitution-dependent decrease in affinity constants. The practical consequences of altered binding parameters were demonstrated by quantitating specific antibody accumulation in melanoma transplants in vivo.
Similar articles
-
Iodination of monoclonal IgG antibodies at a sub-stoichiometric level: immunoreactivity changes related to the site of iodine incorporation.Int J Rad Appl Instrum B. 1987;14(5):451-7. doi: 10.1016/0883-2897(87)90109-7. Int J Rad Appl Instrum B. 1987. PMID: 3117738
-
Improvement by affinity chromatography on antiidiotypic monoclonal antibodies (MAbs) of immunoreactivity and in vivo targeting of radiolabelled anti-HMW-MAA MAb TP61.5 in nude mice bearing human melanoma lesions.Int J Cancer. 1991 Oct 21;49(4):624-30. doi: 10.1002/ijc.2910490426. Int J Cancer. 1991. PMID: 1917164
-
Improved tumor targeting of rhenium-186-labeled anti-human high-m.w. melanoma-associated antigen monoclonal antibody 763.74 following purification with anti-idiotypic monoclonal antibody MK2-23.Int J Cancer. 1998 Nov 9;78(4):486-90. doi: 10.1002/(sici)1097-0215(19981109)78:4<486::aid-ijc15>3.0.co;2-4. Int J Cancer. 1998. PMID: 9797138
-
Specific localization, gamma camera imaging, and intracellular trafficking of radiolabelled chimeric anti-G(D3) ganglioside monoclonal antibody KM871 in SK-MEL-28 melanoma xenografts.Cancer Res. 2001 Jun 1;61(11):4474-82. Cancer Res. 2001. PMID: 11389078
-
Radioimmunoimaging of malignant melanoma with monoclonal antibodies.Cancer Treat Res. 1988;43:123-53. doi: 10.1007/978-1-4613-1751-7_8. Cancer Treat Res. 1988. PMID: 2908570 Review. No abstract available.
Cited by
-
Antibody transport and internalization into tumours.Br J Cancer Suppl. 1990 Jul;10:1-5. Br J Cancer Suppl. 1990. PMID: 2383472 Free PMC article.
-
Criteria for selecting monoclonal antibodies with respect to accumulation in melanoma tissue.Cancer Immunol Immunother. 1987;24(2):151-7. doi: 10.1007/BF00205593. Cancer Immunol Immunother. 1987. PMID: 3829049 Free PMC article.
-
Factors affecting the antigen-antibody reaction.Blood Transfus. 2007 Nov;5(4):227-40. doi: 10.2450/2007.0047-07. Blood Transfus. 2007. PMID: 19204779 Free PMC article. No abstract available.
-
The binding parameters of radiolabelled monoclonal F (ab')2 and Fab' fragments relative to immunoglobulin G in reactions with surface-bound antigens.Eur J Nucl Med. 1992;19(6):402-8. doi: 10.1007/BF00177366. Eur J Nucl Med. 1992. PMID: 1618231
-
Labeling of monoclonal antibodies with a 67Ga-phenolic aminocarboxylic acid chelate. Part II. Comparison of immunoreactivity and biodistribution of monoclonal antibodies labeled with the 67Ga-chelate or with 131I.Eur J Nucl Med. 1986;12(8):405-12. doi: 10.1007/BF00252199. Eur J Nucl Med. 1986. PMID: 3792375
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical